Clinical trial to evaluate the pharmacokinetic behavior of meropenem increased adsorption in membranes (oXiris) in patients with critical septic acute renal dysfunction [ENSAYO CLINICO PARA EVALUAR EL COMPORTAMIENTO FARMACOCINETICO DE MEROPENEM EN MEMBRANAS DE ADSORCION INCREMENTADA (oXiris) EN EL PACIENTE CRITICO SEPTICO CON DISFUNCION RENAL AGUDA]

Trial Profile

Clinical trial to evaluate the pharmacokinetic behavior of meropenem increased adsorption in membranes (oXiris) in patients with critical septic acute renal dysfunction [ENSAYO CLINICO PARA EVALUAR EL COMPORTAMIENTO FARMACOCINETICO DE MEROPENEM EN MEMBRANAS DE ADSORCION INCREMENTADA (oXiris) EN EL PACIENTE CRITICO SEPTICO CON DISFUNCION RENAL AGUDA]

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Mar 2012

At a glance

  • Drugs Meropenem (Primary)
  • Indications Bacterial infections; Sepsis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 19 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top